Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials (2024) Fokas E, Williams H, Diefenhardt M, Lin S, Qin LX, Piso P, Dapper H, et al. Journal article Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials (2024) Choderlos de Laclos X, Risbourg S, Marec-Bérard P, Cécile Le Deley M, Tabone MD, Bertucci F, Gaspar N, et al. Journal article Evaluation of a medical student-delivered smoking prevention program utilizing a face-aging mobile app for secondary schools in Germany: The Education Against Tobacco cluster-randomized controlled trial (2024) Brinker TJ, Krieghoff-Henning EI, Suhre JL, Silchmüller MP, Divizieva E, Wilhelm J, Hillebrand G, et al. Journal article The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany (2024) Krebs M, Haller F, Spörl S, Gerhard-Hartmann E, Utpatel K, Maurus K, Kunzmann V, et al. Journal article Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma (2024) Klümper N, Cox A, Eckstein M, Kuppe C, Ritter M, Brossart P, Luetkens J, et al. Journal article Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors (2024) Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, Dücker P, et al. Journal article Disease-free survival as a surrogate for overall survival in HR+/HER2– early breast cancer: A correlation analysis (2024) Untch M, Pérol D, Mayer EL, Cortes J, Nusch A, Cameron D, Barrios C, et al. Journal article Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB (2024) Amaral T, Nanz L, Stadler R, Berking C, Ulmer A, Forschner A, Meiwes A, et al. Journal article The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects (2024) Ertl C, Ruf T, Mentzer D, Kong M, Kramer R, Bergwelt-Baildon Mv, Subklewe M, et al. Journal article